Literature DB >> 6722834

Evaluation of vinblastine administered by 5-day continuous infusion in women with advanced breast cancer.

J N Ingle, D L Ahmann, J G Gerstner, S J Green, M J O'Connell, L K Kvols.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6722834

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  2 in total

1.  Phase II study of divided-dose vinblastine in advanced breast cancer patients.

Authors:  G Giaccone; M Bagatella; O Bertetto; M Donadio; A Calciati
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  Phase II study of a combination of elliptinium and vinblastine in metastatic breast cancer.

Authors:  L Kayitalire; F Thomas; T Le Chevalier; C Toussaint; T Tursz; M Spielmann
Journal:  Invest New Drugs       Date:  1992-11       Impact factor: 3.850
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.